Mumbai-based Gem Aromatics Ltd. has commenced commercial production of new high-value specialty ingredients at its Dahej, Gujarat facility through its wholly owned subsidiary Krystal Ingredients Pvt. Ltd., marking a key milestone in its forward integration and portfolio diversification strategy.
The newly introduced products—GEM Cool 5 (a proprietary cooling agent) and Safranal (a citral derivative)—expand the company’s presence in performance-driven aroma chemicals. These products cater to high-growth end-use segments such as oral care, personal care, and fine fragrances, where demand is increasingly shifting toward differentiated, functional ingredients with higher margins.
This follows the earlier commissioning of WS-23, WS-03 cooling agents and clove derivatives (eugenol, clove oil), indicating a phased scale-up of the Dahej facility. The company’s focus on synthetic cooling agents is strategically aligned with a niche segment witnessing above-industry growth, driven by rising demand for controlled sensory performance in FMCG formulations.
From an industry perspective, the global flavors and fragrances market is estimated at approximately ₹2.9–3.3 lakh crore, growing at ~5% CAGR. Within this, aroma chemicals account for nearly ₹40,000–58,000 crore. India’s aroma chemicals market, valued at over ₹12,000 crore, continues to gain traction in global supply chains due to cost competitiveness and increasing backward integration.
Importantly, Gem Aromatics Ltd. is also progressing toward commissioning a catalyst for MEHQ (Monomethyl Ether of Hydroquinone), targeted for Q4FY26. This initiative could support margin expansion through backward integration and improved control over key intermediates.
On the demand front, the company is witnessing a revival in exports, supported by easing tariff pressures in the US and progress on the proposed India–EU FTA. Export orders worth approximately ₹8–9 crore have already been secured, with improving inquiry conversion indicating stronger near-term revenue visibility.
Management commentary indicates that previously deferred demand is returning, translating into a strengthening order pipeline. With ongoing capacity additions, a more diversified product mix, and improving global trade conditions, the company appears well-positioned to drive sustainable revenue growth and margin improvement going forward.